Kim Smith-Whitley

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Smith-Whitley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Global Blood Therapeutics, Inc. Officer Title: EVP, Head of Research & Development Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Officer Title: EVP, Head of Research & Development Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Officer Title: EVP, Head of Research & Development Stock Option (Right to Buy) 0 05 Oct 2022 Direct

Insider Reports Filed by Kim Smith-Whitley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322033151-smith-whitley-kim-2022-10-05 Global Blood Therapeutics, Inc. 05 Oct 2022 7 $0 4 Officer Title: EVP, Head of Research & Development 06 Oct 2022, 16:15
/report/000089924322030478-smith-whitley-kim-2022-09-01 Global Blood Therapeutics, Inc. 01 Sep 2022 3 -$41,367 4 Officer Title: EVP, Head of Research & Development 06 Sep 2022, 19:00
/report/000089924322021008-smith-whitley-kim-2022-06-01 Global Blood Therapeutics, Inc. 01 Jun 2022 3 -$39,873 4 Officer Title: EVP, Head of Research & Development 03 Jun 2022, 17:06
/report/000089924322009243-smith-whitley-kim-2022-03-01 Global Blood Therapeutics, Inc. 01 Mar 2022 3 $0 4 Officer Title: EVP, Head of Research & Development 03 Mar 2022, 19:55
/report/000089924321024951-smith-whitley-kim-2021-06-01-restatement Global Blood Therapeutics, Inc. 01 Jun 2021 1 $0 4/A Officer 21 Jun 2021, 16:05
/report/000089924321018688-smith-whitley-kim-2021-05-03 Global Blood Therapeutics, Inc. 03 May 2021 0 $0 3 EVP, Head of Research & Development EXHIBIT 24: POWER OF ATTORNEY 07 May 2021, 16:40